肝細胞肝癌靶向性r-Caspase-3重組腺病毒的構建與表達_《中國普外基礎與臨床雜志》

作者：

王煒 , 程衛 , 丘昶儒

廣州醫學院第一附屬醫院肝膽外科（廣州 510120）;

關鍵詞：

腺病毒反向半胱氨酸蛋白酶3基因靶向性肝細胞肝癌

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

目的　構建肝細胞肝癌特異性表達反向半胱氨酸蛋白酶3（r-Caspase-3）重組腺病毒，為肝細胞肝癌的基因治療提供新策略。
方法　構建甲胎蛋白（AFP）增強子和白蛋白 (ALB) 啟動子腺病毒載體（pAdTrack-EAFP-PALB），然后將目的基因r-Caspase-3亞克隆到載體pAdTrack-EAFP-PALB上，獲得重組腺病毒穿梭載體pAdTrack-EAFP-PALB /r-Caspase-3, 經PmeⅠ酶切線性化后與pAdEasy-1同源重組，獲得重組腺病毒骨架pAdEasy-EAFP-PALB /r-Caspase-3；鑒定正確的pAdEasy-EAFP-PALB/r-Caspase-3 經PacⅠ酶切線性化后脂質體轉染AD293 細胞進行包裝、擴增，獲得病毒。綠色熒光蛋白(green fluorescent protein，GFP)監測病毒滴度和感染效率； RT-PCR和Western blot 法檢測r-Caspase-3在HepG2細胞中的表達； SRB染色法評估重組腺病毒對HepG2細胞的抑制作用，初步觀察HepG2細胞凋亡狀況。
結果　穿梭載體pAdTrack-EAFP-PALB/r-Caspase-3酶切、測序正確。穿梭載體、pAdEasy-1載體同源重組后PCR 及PacⅠ酶切鑒定結果表明pAdEasy-EAFP-PALB/r-Caspase-3 重組成功；經PacⅠ酶切線性化后，pAdEasy-EAFP-PALB/r-Caspase-3 轉染AD293 細胞即可觀察到GFP 的表達；回收病毒可重復感染AD293 細胞，RT-PCR和Western blot 均可檢測到r-Caspase-3的表達，證實Ad-EAFP-PALB/r-Caspase-3病毒顆粒包裝成功； SRB染色檢測發現Ad-EAFP-PALB/r-Caspase-3具有凋亡誘導特異性。
結論　靶向性Ad-EAFP-PALB/r-Caspase-3重組腺病毒構建成功，并具有凋亡誘導靶向性，為進一步研究靶向性r-Caspase-3基因治療肝細胞肝癌及其生物學功能奠定了基礎。

引用本文： 王煒,程衛,丘昶儒. 肝細胞肝癌靶向性r-Caspase-3重組腺病毒的構建與表達. 中國普外基礎與臨床雜志, 2008, 15(8): 589-594. doi: 復制

1.	13　Fujikawa K, Shiraki K, Sugimoto K, et al. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma [Ｊ]. Anticancer Res, 2000; 20(3B)∶1927 14　Hoshi T, Sasano H, Kato K, et al. Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis [Ｊ]. Anticancer Res, 1998; 18(6A)∶4347 15　Srinivasula SM, Ahmad M, MacFarlane M, et al. Generation of constitutively active recombinant caspases-3 and-6 by rearrangement of their subunits [Ｊ]. J Biol Chem， 1998； 273(17)∶10107.
2.	Lam PY, Sia KC, Khong JH, et al. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas [Ｊ]. Mol Ther, 2007; 15(6)∶1129.
3.	Pin RH, Reinblatt M, Fong Y. Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma [Ｊ]. Ann Surg, 2004; 240(4)∶659.
4.	He P, Tang ZY, Ye SL, et al. The targeted expression of interleukin-2 in human hepatocellular carcinoma cells [Ｊ]. J Exp Clin Cancer Res, 2000; 19(2)∶183.
5.	He P, Tang ZY, Liu BB, et al. The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells [Ｊ]. J Cancer Res Clin Oncol, 1999; 125(2)∶77.
6.	王煒，秦兆寅，王劍利，等. 重組的r-Caspase-3促凋亡基因體內外治療胰腺癌的試驗研究 [Ｊ]. 中華肝膽外科雜志， 2003； 9(5)∶303.
7.	王煒，秦兆寅，劉志國. 重組型Caspase-3基因的構建及其在胰腺癌細胞中凋亡活性的觀察 [Ｊ]. 中國普外基礎與臨床雜志， 2002； 9(4)∶249.
8.	鄭仲承. 寡核苷酸的優化設計 [Ｊ]. 生命的化學, 2001; 21(3)∶ 254.
9.	He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses [Ｊ]. Proc Natl Acad Sci USA， 1998； 95(5)∶2509.
10.	沈鼎明，黃愛龍，肖彧君，等. NF-κB 超抑制物κIBαM 重組腺病毒的構建 [Ｊ]. 免疫學雜志， 2004； 20(1)∶65.
11.	Yang LQ, Fang DC, Wang RQ, et al. Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand [Ｊ]. World J Gastroenterol, 2004； 10(1)∶22.
12.	Meggiato T, Calabrese F, De Cesare CM, et al. C-JUN and CPP32 (CASPASE 3) in human pancreatic cancer: relation to cell proliferation and death [Ｊ]. Pancreas, 2003; 26(1)∶65.
13.	Condorelli G, Roncarati R, Ross J Jr, et al. Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function [Ｊ]. Proc Natl Acad Sci USA, 2001; 98 (17)∶ 9977.
14.	Manekeller S, Sioutis M, Hirner A, et al. Influence of neoadjuvant chemotherapy on liver integrity and ischemic tolerance [Ｊ]. Z Gastroenterol, 2008； 46(1)∶17.
15.	Niu J, Li XN, Qian H, et al. siRNA mediated the type 1 insulin-like growth factor receptor and epidermal growth factor receptor silencing induces chemosensitization of liver cancer cells [Ｊ]. J Cancer Res Clin Oncol, 2008; 134(4)∶503.
16.	Park HJ, Shin DH, Chung WJ, et al. Epigallocatechin gallate reduces hypoxia-induced apoptosis in human hepatoma cells [Ｊ]. Life Sci, 2006; 78(24)∶2826.
17.	Nakanishi H, Yasui K, Ikehara Y, et al. Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis [Ｊ]. Clin Exp Metastasis, 2005; 22(2)∶ 137.
18.	Dotti G, Savoldo B, Pule M, et al. Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis [Ｊ]. Blood, 2005; 105(12)∶4677.

1. 13　Fujikawa K, Shiraki K, Sugimoto K, et al. Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma [Ｊ]. Anticancer Res, 2000; 20(3B)∶1927 14　Hoshi T, Sasano H, Kato K, et al. Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis [Ｊ]. Anticancer Res, 1998; 18(6A)∶4347 15　Srinivasula SM, Ahmad M, MacFarlane M, et al. Generation of constitutively active recombinant caspases-3 and-6 by rearrangement of their subunits [Ｊ]. J Biol Chem， 1998； 273(17)∶10107.
2. 　Lam PY, Sia KC, Khong JH, et al. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas [Ｊ]. Mol Ther, 2007; 15(6)∶1129.
3. 　Pin RH, Reinblatt M, Fong Y. Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma [Ｊ]. Ann Surg, 2004; 240(4)∶659.
4. 　He P, Tang ZY, Ye SL, et al. The targeted expression of interleukin-2 in human hepatocellular carcinoma cells [Ｊ]. J Exp Clin Cancer Res, 2000; 19(2)∶183.
5. 　He P, Tang ZY, Liu BB, et al. The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells [Ｊ]. J Cancer Res Clin Oncol, 1999; 125(2)∶77.
6. 　王煒，秦兆寅，王劍利，等. 重組的r-Caspase-3促凋亡基因體內外治療胰腺癌的試驗研究 [Ｊ]. 中華肝膽外科雜志， 2003； 9(5)∶303.
7. 　王煒，秦兆寅，劉志國. 重組型Caspase-3基因的構建及其在胰腺癌細胞中凋亡活性的觀察 [Ｊ]. 中國普外基礎與臨床雜志， 2002； 9(4)∶249.
8. 　鄭仲承. 寡核苷酸的優化設計 [Ｊ]. 生命的化學, 2001; 21(3)∶ 254.
9. 　He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses [Ｊ]. Proc Natl Acad Sci USA， 1998； 95(5)∶2509.
10. 　沈鼎明，黃愛龍，肖彧君，等. NF-κB 超抑制物κIBαM 重組腺病毒的構建 [Ｊ]. 免疫學雜志， 2004； 20(1)∶65.
11. 　Yang LQ, Fang DC, Wang RQ, et al. Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand [Ｊ]. World J Gastroenterol, 2004； 10(1)∶22.
12. 　Meggiato T, Calabrese F, De Cesare CM, et al. C-JUN and CPP32 (CASPASE 3) in human pancreatic cancer: relation to cell proliferation and death [Ｊ]. Pancreas, 2003; 26(1)∶65.
13. 　Condorelli G, Roncarati R, Ross J Jr, et al. Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function [Ｊ]. Proc Natl Acad Sci USA, 2001; 98 (17)∶ 9977.
14. 　Manekeller S, Sioutis M, Hirner A, et al. Influence of neoadjuvant chemotherapy on liver integrity and ischemic tolerance [Ｊ]. Z Gastroenterol, 2008； 46(1)∶17.
15. 　Niu J, Li XN, Qian H, et al. siRNA mediated the type 1 insulin-like growth factor receptor and epidermal growth factor receptor silencing induces chemosensitization of liver cancer cells [Ｊ]. J Cancer Res Clin Oncol, 2008; 134(4)∶503.
16. 　Park HJ, Shin DH, Chung WJ, et al. Epigallocatechin gallate reduces hypoxia-induced apoptosis in human hepatoma cells [Ｊ]. Life Sci, 2006; 78(24)∶2826.
17. 　Nakanishi H, Yasui K, Ikehara Y, et al. Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis [Ｊ]. Clin Exp Metastasis, 2005; 22(2)∶ 137.
18. 　Dotti G, Savoldo B, Pule M, et al. Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis [Ｊ]. Blood, 2005; 105(12)∶4677.

《中國普外基礎與臨床雜志》

肝細胞肝癌靶向性r-Caspase-3重組腺病毒的構建與表達

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國普外基礎與臨床雜志》

肝細胞肝癌靶向性r-Caspase-3重組腺病毒的構建與表達

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料